A study looking at adding treatment to chemotherapy for acute lymphoblastic leukaemia that has not responded, or has come back after treatment (MARALL)

Overview

Cancer types:

Acute leukaemia, Acute lymphoblastic leukaemia (ALL), Leukaemia

Status:

Results

Phase:

Phase 1/2

Details

This study looked at veltuzumab and epratuzumab with chemotherapy for acute lymphoblastic leukaemia (ALL) that has not responded to treatment, or has come back. This study was supported by Cancer Research UK.

Recruitment start: 6 December 2010

Recruitment end: 10 October 2014

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Matthew Smith

Supported by

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

Immunomedics Inc

NIHR Clinical Research Network: Cancer

Queen Mary University of London

Other information

This is Cancer Research UK trial number CRUK/08/040.

Last reviewed: 15 November 2017

CRUK internal database number: 4550

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Help and support

Questions for your doctor

What to ask your doctor about clinical trials.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.